Brief: Melodiol Global Health Secures Non-Binding LOI With Panacea Life Sciences
Aug 2 (Reuters) - Melodiol Global Health Ltd ME1.AX :
* SECURES A NON-BINDING LOI WITH PANACEA LIFE SCIENCES
HOLDINGS
* LOI INCLUDES ADDITIONAL EARN-OUT COMPONENTS VALUED AT UP
TO
US$15M
* LOI FOR SALE OF SIERRA SAGES HERBS, LLC AND HALUCENEX LIFE
SCIENCES FOR AN INITIAL APPROXIMATE US$5M IN CASH AND SCRIP
VALUE
* POST-TRANSACTION, MELODIOL WILL BE LARGEST SHAREHOLDER IN
PANACEA
Source text for Eikon: ID:nASX8GFnZ
Further company coverage: ME1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale